Trials / Completed
CompletedNCT06150053
Dose Dense Chemotherapy in Elderly Patients > 80 Years Old With DLBCL
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 79 (actual)
- Sponsor
- University Hospital, Saarland · Academic / Other
- Sex
- All
- Age
- 80 Years
- Healthy volunteers
- Not accepted
Summary
Multi-center retrospective analysis of patients with DLBCL aged ≥80 years old treated with R-CHOP-14 compared to other regimens. Patient data including baseline characteristics, histology, dose intensity and treatment outcomes will be extracted from hospital medical electronic records. Relative dose intensity (RDI) will be calculated as the percentage of the dose intensity achieved divided by the intended dose intensity. Primary endpoints are overall (OS), progression-free (PFS) and event-free survival (EFS), defined as time from diagnosis to death, death or progression/relapse, progression/relapse or treatment discontinuation.
Conditions
Timeline
- Start date
- 2018-07-01
- Primary completion
- 2023-01-01
- Completion
- 2023-11-01
- First posted
- 2023-11-29
- Last updated
- 2023-11-29
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT06150053. Inclusion in this directory is not an endorsement.